News from Intezyne Technologies, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 06, 2017, 08:30 ET Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development

Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it closed an...


Jun 20, 2017, 08:30 ET Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer

Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that that the Office of Orphan...


Mar 31, 2017, 14:13 ET Intezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR Symposium

Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has initiated...